Usern_member

Hamid Badali

USERN Advisory Board

Curriculum Vitae


Personal Information:                 


First Name: Hamid                                 


Last Name: Badali                                 


Gender: Male                                           


Date of Birth: 15.April.1977


Place of Birth: Zanjan-Iran                   


Nationality: Iranian


Address: Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. P.O. Box: 48175-1665


Fax: +98 11 3354 3087; Mobile: +98-912-841-3720


E-Mail: [email protected]


E-Mail: [email protected]


 


Present Statuas:


Associate professor; PhD


Departments of Medical Mycology/Invasive Fungi Research Center, School of Medicine, Mazandaran University of Medical Sciences Sari- Iran


 


Educational Records:


1995 -1999: BSc: Cellular & molecular Microbiology, Zanjan University of medical Science. Iran (Date of graduated 19 Sept 1999) 16.04 of 20


2000-2003: MSc: Medical Mycology. Mazandaran University of Medical Sciences - Iran (Date of graduated 7 Dec 2002) 16.75 of 20


2006-2010: PhD:  Medical and Molecular Mycology. Amsterdam University, Fungal Biodiversity Centre and in CBS institute –Netherlands (Date of graduated 25th June 2010)


 


Publications:


 


64. Sharifynia S, Badali H, Sharifi Sorkherizi M, Shidfar MR, Hadian A, Shahrokhi S, Ghandchi G, Rezaie S. In Vitro Antifungal Susceptibility Profiles of Candida albicans Complex Isolated from Patients with Respiratory Infections. Acta Med Iran 2016; 54(6):376-81. PubMed PMID: 27306344.


63. Nabili M, Abdollahi Gohar A,  Badali H,  Mohammadi R,Moazeni M. Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: possible effective substitutions and homology modelling. Journal of Global Antimicrobial Resistance 5 (2016) 42–46.


62. Baghi N, Shokohi T, Badali H, Makimura K, Rezaei-Matehkolaei A, Abdollahi M, Didehdar M, Haghani I, Abastabar M. In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates. Med Mycol. 2016 Apr 26. pii: myw016. PMID: 27118804


61. Abastabar M, Mirhendi H, Hedayati MT, Shokohi T, Rezaei-Matehkolaei A, Mohammadi R, Badali H, Moazeni M, Haghani I, Ghojoghi A, Akhtari J. Genetic and Morphological Diversity of the Genus Penicillium From Mazandaran and Tehran Provinces, Iran. Jundishapur J Microbiol. 2016 Jan 9;9(1):e28280. doi: 10.5812/jjm.28280. eCollection 2016 Jan. PMID: 27099684


60. Nabili M, Shokohi T, Moazeni M, Khodavaisy S, Aliyali M, Badiee P, Zarrinfar H, Hagen F, Badali H*. High Prevalence of Clinical and Environmental Triazole Resistant Aspergillus fumigatus in Iran: Is It a Challenging Issue?. J Med Microbiol. 2016 Mar 23. doi: 10.1099/jmm.0.000255.


59. Khodavaisy S, Badali H, Hashemi SJ, Aala F, Nazeri M, Nouripour-Sisakht S, Sorkherizi MS, Amirizad K, Aslani N, Rezaie S. In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen. J Mycol Med. 2016 Mar 2. pii: S1156-5233(16)00006-8. doi: 10.1016/j.mycmed.2016.01.002. PMID: 26948143


58. Vaezi A, Moazeni M, Rahimi MT, de Hoog S, Badali H*. Mucormycosis in Iran: a systematic review. Mycoses. 2016 Feb 15. doi: 10.1111/myc.12474. PMID: 26906121


57. Khodavaisy S, Badali H, Rezaie S, Nabili M, Moghadam KG, Afhami S, Hagen F, Aala F, Hashemi SJ, Meis JF. Genotyping of clinical and environmental Aspergillus flavus isolates from Iran using microsatellites. Mycoses. 2016 Jan 12. doi: 10.1111/myc.12451. PMID: 26756650


56. Aliyali M, Badali H, Shokohi T, Moazeni M, Nosrati A, Godazandeh G, Dolatabadi, S, Nabili M. Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review. Mycopathologia. 2016 Apr; 181(3-4):255-65. doi: 10.1007/s11046-015-9974-2. PMID: 26666549


55. Badali H, Fakhim H, Zarei F, Nabili M, Vaezi A, Poorzad N, Dolatabadi S, Mirhendi H. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex. Mycopathologia. 2016 Apr; 181(3-4):235-40. doi: 10.1007/s11046-015-9968-0. Epub 2015 Nov 28. PMID: 26615417


54. Afsarian SM, Badali H, Shokohi T, Najafipour S. Molecular Diversity of Candida albicans Isolated from Immunocompromised Patients, Based on MLST Method. Iran J Public Health. 2015 Sep;44(9):1262-1269. PubMed PMID: 26587501; PMC4645784.


53. Deng S, Tsui CK, Gerrits van den Ende AH, Yang L, Najafzadeh MJ, Badali H, Li R, Hagen F, Meis JF, Sun J, Dolatabadi S, Papierok B, Pan W, de Hoog GS, Liao W. Global Spread of Human Chromoblastomycosis Is Driven by Recombinant Cladophialophora carrionii and Predominantly Clonal Fonsecaea Species. PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004004. doi: 10.1371/journal.pntd.0004004.eCollection 2015 Oct. PubMed PMID: 26496430; PubMed Central PMCID: PMC4619687. 


52. Afshar P, Hedayati MT, Aslani N, Khodavaisy S, Babamahmoodi F, Mahdavi MR, Dolatabadi S, Badali H*. First Autochthonous Coinfected Anthrax in an Immunocompetent Patient. Case Rep Med. 2015;2015:325093. doi:10.1155/2015/325093. Epub 2015 Sep 15. PubMed PMID: 26451148; PubMed Central PMCID: PMC4586956.


51. Mousavi B, Hedayati MT, Teimoori-Toolabi L, Guillot J, Alizadeh A, Badali H*. cyp51A gene silencing using RNA interference in azole-resistant Aspergillus fumigatus. Mycoses. 2015 Dec; 58(12):699-706. doi: 10.1111/myc.12417. PubMed PMID: 26448519. 


50. Badali H, Alian S, Fakhim H, Falahatinejad M, Moradi A, Mohammad Davoudi M, Hagen F, Meis JF. Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature. Mycoses. 2015 Dec; 58(12):689-93.doi: 10.1111/myc.12415. PMID: 26444438. 


49. Zakeri H, Shokohi T, Badali H, Mayahi S, Didehdar M. Use of Padlock Probes and Rolling Circle Amplification (RCA) for Rapid Identification of Trichophyton Species, Related to Human and Animal Disorder. Jundishapur J Microbiol. 2015 Jul  27;8(7):e19107. doi: 10.5812/jjm.19107v2. eCollection 2015 Jul. PubMed PMID: 26421127


48. Badali H, Khodavaisy S, Fakhim H, de Hoog GS, Meis JF, Chowdhary A. In Vitro Susceptibility Profiles of Eight Antifungal Drugs Against Clinical and Environmental Strains of Phaeoacremonium. Antimicrob Agents Chemother. 2015 Dec; 59(12):7818-22. doi: 10.1128/AAC.01733-15. PMID: 26369976


47. Ansari S, Hedayati MT, Zomorodian K, Pakshir K, Badali H, Rafiei A, Ravandeh M, Seyedmousavi S. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran. Mycopathologia. 2016 Feb; 181(1-2):89-95. doi: 10.1007/s11046-015-9941-y. Epub 2015 Sep 14. PMID: 26369643


 46. Mohammadi R, Abastabar M, Mirhendi H, Badali H, Shadzi S, Chadeganipour M, Pourfathi P, Jalalizand N, Haghani I. Use of Restriction Fragment Length Polymorphism to Rapidly Identify Dermatophyte Species Related to Dermatophytosis. Jundishapur J Microbiol. 2015 Jun 30;8(6):e17296. doi: 10.5812/jjm.8(5)2015.17296.


45. Yazdanparast SA1, Khodavaisy S, Fakhim H, Shokohi T, Haghani I, Nabili M, Gholami H, Ahmadi I, Badali H*. Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis. Mycopathologia; 2015 Dec; 180(5-6):317-23. doi: 10.1007/s11046-015-9924-z. PMID: 26183965


44. Mohammadi R, Badiee P, Badali H, Abastabar M, Safa AH, Hadipour M, Yazdani H, Heshmat F. Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Adv Biomed Res. 2015 May 11; 4:95. doi: 10.4103/2277-9175.156659. eCollection 2015. PMID: 26015921


43. Badali H, Mohammadi R, Mashedi O, de Hoog GS, Meis JF. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs. Mycoses. 2015 May; 58(5):303-7. doi: 10.1111/myc.12315. PMID: 25757042. 


42. Hashemi SM, Badali H, Irannejad H, Shokrzadeh M, Emami S. Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents. Bioorg Med Chem. 2015 Apr 1; 23(7):1481-91. doi: 10.1016/j.bmc.2015.02.011. PMID: 25740636.


41. Didehdar M, Gokanian A, Sofian M, Mohammadi S, Mohammadi R, Aslani N, Haghani I, Badali H*. First fatal cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran, based on ITS rDNA. J Mycol Med. 2015 Mar;25(1):81-6. doi: 10.1016/j.mycmed.2014.11.003; PMID:25637429


40. Afsarian MH, Badali H, Boekhout T, Shokohi T, Katiraee F. Multilocus sequence typing of Candida albicans isolates from Burn Intensive Care Unit (BICU) in Iran. J Med Microbiol. 2015 Mar;64(Pt 3):248-53. doi: 10.1099/jmm.0.000015. PMID: 25596113


39. Hashemi SM, Badali H, Faramarzi MA, Samadi N, Afsarian MH, Irannejad H, Emami S. Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity. Mol Divers 2015; 19:15–27. PMID: 25182365.


38. Babazadeh-Qazijahani M, Badali H, Irannejad H, Afsarian MH, Emami S. Imidazolylchromanones containing non-benzylic oxime ethers: synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii. Eur J Med Chem 2014; 76: 264 -73. doi: 10.1016/j.ejmech.2014.02.019. PubMed PMID: 24583607.


37. Pei-Ying Feng, G. S. de Hoog, M. J. Najafzadeh, A. H. G. Gerrits van den Ende, J. B. Stielow, H. Badali, W. A. Boeger, V. A. Vicente. Cladophialophora abundans, a novel species of Chaetothyriales isolated from the natural environment. Mycological Progress 2014; DOI 10.1007/s11557-013-0924-4


36. Fesharaki SH, Haghani I, Mousavi B, Kargar ML, Boroumand M, Anvari MS, Abbasi K, Meis JF, Badali H*. Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser. J Med Microbiol. 2013 Nov; 62 (Pt 11):1763-7.  doi: 10.1099/jmm.0.060954-0. PubMed PMID: 23973985. 


35. Badali H, Vaezi A, Haghani I, Yazdanparast SA, Hedayati MT, Mousavi B, Ansari S, Hagen F, Meis JF, Chowdhary A. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses. 2013 Nov; 56(6):659-63. doi: 10.1111/myc.12089. PubMed PMID: 23668594. 


34. Badali H, Fernández-González M, Mousavi B, Illnait-Zaragozi MT, González-Rodríguez JC, de Hoog GS, Meis JF. Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba. Mycopathologia. 2013 Jun; 175(5-6):439-44. doi: 10.1007/s11046-013-9634-3. PubMed PMID: 23471535. 


33. Bonifaz A, Davoudi MM, de Hoog GS, Padilla-Desgarennes C, Vázquez-González D, Navarrete G, Meis JF, Badali H*. Severe disseminated phaeohyphomycosis in an immunocompetent patient caused by Veronaea botryosa. Mycopathologia. 2013 Jun; 175(5-6):497-503. doi: 10.1007/s11046-013-9632-5. PubMed PMID: 23471534.


32. Hamzehei H, Yazdanparast SA, Davoudi MM, Khodavaisy S, Golehkheyli M, Ansari S, de Hoog GS, Badali H*. Use of rolling circle amplification to rapidly identify  species of Cladophialophora potentially causing human infection. Mycopathologia. 2013 Jun; 175(5-6):431-8. doi: 10.1007/s11046-013-9630-7. PubMed PMID: 23471533. 


31. Badali H, Yazdanparast SA, Bonifaz A, Mousavi B, de Hoog GS, Klaassen CH, Meis JF. Veronaea botryosa: molecular identification with amplified fragment length polymorphism (AFLP) and in vitro antifungal susceptibility. Mycopathologia. 2013 Jun; 175(5-6):505-13. doi: 10.1007/s11046-013-9631-6. PubMed PMID: 23463524. 


30. Pattanaprichakul P, Bunyaratavej S, Leeyaphan C, Sitthinamsuwan P, Sudhadham M, Muanprasart C, Feng P, Badali H, de Hoog GS. An unusual case of Eumycetoma caused by Exophiala jeanselmei after a sea urchin injury. Mycoses. 2013 Jul;56(4):491-4. doi: 10.1111/myc.12050. PubMed PMID: 23406480. 


29. Deng S, de Hoog GS, Badali H, Yang L, Najafzadeh MJ, Pan B, Curfs-Breuker I, Meis JF, Liao W. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis. Antimicrob Agents Chemother. 2013 Apr; 57(4):1974-7. doi: 10.1128/AAC.02114-12. PubMed PMID: 23380718;


28. Arzanlou M, Moshari S, Salari M, Badali H*. Molecular characterization and pathogenicity of Phaeoacremonium spp. associated with esca disease of grapevine in Northern Iran. Archives of Phytopathology and Plant Protection 2013; 46(4): 375–388 


27. Mirhendi H, Fatemi MJ, Bateni H, Hajabdolbaghi M, Geramishoar M, Ahmadi B, Badali H*. First case of disseminated phaeohyphomycosis in an immunocompetent individual due to Alternaria malorum. Med Mycol. 2013 Feb; 51(2):196-202. doi: 10.3109/13693786.2012.707338. PubMed PMID: 22871097.


26. Agha Kuchak Afshari S, Shokohi T, Aghili R, Badali H. Epidemiology and molecular characterization of Cryptococcus neoformans isolated from pigeon excreta in Mazandaran province, northern Iran. J Mycol Med. 2012 Jun; 22(2):160-6. doi: 0.1016/j.mycmed.2012.02.002. PubMed PMID: 23518018. 


25. Badali H, Chander J, Bayat M, Seyedmousavi S, Sidhu S, Rani H, Attri A, Handa U, Meis JF, de Hoog GS. Multiple subcutaneous cysts due to Exophiala spinifera in an immunocompetent patient. Med Mycol. 2012 Feb; 50(2):207-13. doi: 10.3109/13693786.2011.603367. PubMed PMID: 21916783. 


24. de Hoog GS, Vicente VA, Najafzadeh MJ, Harrak MJ, Badali H, Seyedmousavi S. Waterborne Exophiala species causing disease in cold-blooded animals. Persoonia. 2011 Dec; 27:46-72. doi: 10.3767/003158511X614258. PubMed PMID: 22403476 


23. Seyedmousavi S, Badali H, Chlebicki A, Zhao J, Prenafeta-Boldú FX, De Hoog GS. Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic. Fungal Biol. 2011 Oct; 115(10):1030-7. doi: 10.1016/j.funbio.2011.06.004. PubMed PMID: 21944215. 


22. Badali H, Prenafeta-Boldu FX, Guarro J, Klaassen CH, Meis JF, de Hoog GS. Cladophialophora psammophila, a novel species of Chaetothyriales with a potential use in the bioremediation of volatile aromatic hydrocarbons. Fungal Biol. 2011 Oct; 115(10):1019-29. doi: 10.1016/j.funbio.2011.04.005. PubMed PMID: 21944214. 


21. Sun J, Zhang J, Najafzadeh MJ, Badali H, Li X, Xi L, de Hoog GS. Melanization of a meristematic mutant of Fonsecaea monophora increases tolerance to stress factors while no effects on antifungal susceptibility. Mycopathologia. 2011 Nov; 172(5):373-80. doi: 10.1007/s11046-011-9439-1. PubMed PMID: 21706309. 


20. Badali H, de Hoog GS, Sudhadham M, Meis JF. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist. Med Mycol. 2011 Nov; 49(8):819-24. doi: 10.3109/13693786.2011.583285. PubMed PMID: 21612562. 


19. Badali H, Hedayati MT, Bahoosh M, Kasir A, Ghasemi M, Motahari J, Meis JF, De Hoog GS. Exophiala oligosperma involved in a refractory chronic rhinosinusitis. Eur Rev Med Pharmacol Sci. 2011 Mar; 15(3):319-23. PubMed PMID: 21528779. 


18. Badali H, Chander J, Gupta A, Rani H, Punia RS, De Hoog GS, Meis JF. Fatal cerebral phaeohyphomycosis in an immunocompetent individual due to Thielavia subthermophila. J Clin Microbiol. 2011 Jun; 49(6):2336-41. doi: 10.1128/JCM.02648-10. PubMed PMID: 21411574 


17. Badali H, Chander J, Gulati N, Attri A, Chopra R, Najafzadeh MJ, Chhabra S, Meis JF, de Hoog GS. Subcutaneous phaeohyphomycotic cyst caused by Pyrenochaeta romeroi. Med Mycol. 2010 Aug; 48(5):763-8. PubMed PMID: 20648971. 


16. Badali H, de Hoog GS, Curfs-Breuker I, Klaassen CH, Meis JF. Use of amplified fragment length polymorphism to identify 42 Cladophialophora strains related to cerebral phaeohyphomycosis with in vitro antifungal susceptibility. J Clin Microbiol. 2010 Jul; 48(7):2350-6. doi: 10.1128/JCM.00653-10. PubMed PMID: 20421439


15. Najafzadeh MJ, Badali H, Illnait-Zaragozi MT, De Hoog GS, Meis JF. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrob Agents Chemother. 2010 Apr; 54(4):1636-8. doi: 10.1128/AAC.01655-09. PubMed PMID: 20086140 


14. Badali H, Bonifaz A, Barrón-Tapia T, Vázquez-González D, Estrada-Aguilar L, Oliveira NM, Sobral Filho JF, Guarro J, Meis JF, De Hoog GS. Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis. Med Mycol. 2010 Aug; 48(5):696-703. doi: 10.3109/13693780903471073. PubMed PMID: 20055741. 


13. Badali H, Chander J, Bansal S, Aher A, Borkar SS, Meis JF, De Hoog GS. First autochthonous case of Rhinocladiella mackenziei cerebral abscess outside the Middle East. J Clin Microbiol. 2010 Feb;48(2):646-9. doi: 10.1128/JCM.01855-09. PubMed PMID: 20007402 


12. Badali H, de Hoog GS, Curfs-Breuker I, Meis JF. In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection. J Antimicrob Chemother. 2010 Jan; 65(1):175-7. doi: 10.1093/jac/dkp390. PubMed PMID: 19854862.


 


11. Badali H, Najafzadeh MJ, van Esbroeck M, van den Enden E, Tarazooie B, Meis JF, de Hoog GS. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species. Med Mycol. 2010 Mar; 48(2):318-27. doi: 10.1080/13693780903148353. PubMed PMID: 19642051. 


10. Najafzadeh MJ, Rezusta A, Cameo MI, Zubiri ML, Yus MC, Badali H, Revillo MJ, De Hoog GS. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora. Med Mycol. 2010 Mar; 48(2):390-3. doi: 10.1080/13693780903008813. PubMed PMID: 19488919. 


9. Badali H, De Hoog GS, Curfs-Breuker I, Andersen B, Meis JF. In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species. J Antimicrob Chemother. 2009 Jun; 63(6):1295-7. doi: 10.1093/jac/dkp109. PubMed PMID: 19336452. 


8. Najafzadeh MJ, Gueidan C, Badali H, Van Den Ende AH, Xi L, De Hoog GS. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea. Med Mycol. 2009 Feb; 47(1):17-25. doi: 10.1080/13693780802527178. PubMed PMID: 19107635. 


7. Nourian AA, Amiri M, Ataeian A, Haniloo A, Mosavinasab SN, Badali H*. eroepidemiological study for toxocariasis among children in Zanjan-northwest of Iran. Pak J Biol Sci. 2008 Jul 15; 11(14):1844-7. PubMed PMID: 18817228. 


6. Badali H, Carvalho VO, Vicente V, Attili-Angelis D, Kwiatkowski IB, Gerrits Van Den Ende AH, De Hoog GS. Cladophialophora saturnica sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol. 2009 Feb; 47(1):51-62. doi: 10.1080/13693780802291452. PubMed PMID: 18720218.


5. Badali H, Gueidan C, Najafzadeh MJ, Bonifaz A, van den Ende AH, de Hoog GS. Biodiversity of the genus Cladophialophora. Stud Mycol. 2008; 61:175-91. doi: 10.3114/sim.2008.61.18. PubMed PMID: 19287540


4. Bonifaz A, Badali H, de Hoog GS, Cruz M, Araiza J, Cruz MA, Fierro L, Ponce RM. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico. Stud Mycol. 2008; 61:77-82. doi: 10.3114/sim.2008.61.07. PubMed PMID: 19287529


3. de Hoog GS, Nishikaku AS, Fernandez-Zeppenfeldt G, Padín-González C, Burger E, Badali H, Richard-Yegres N, van den Ende AH. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud Mycol. 2007; 58:219-34. doi: 10.3114/sim.2007.58.08. PubMed PMID: 18491001


2. Nourian AA, Badali H, Khodaverdi M, Hamzehei H, Mohseni M. Airborne Mycoflora of Zanjan-Iran. Int J Agr Biol 2007; 9: 628-630


1.Nourian AA, Badali H, Hamzehei H. Fungal Contamination in Indoor Swimming Pools in Zanjan-Iran 2005, Pak J Biol Sci 2006; 9: 2524-2527.


 


Congress Presentations:


32) Hamid Badali, Jacques F Meis. In vitro susceptibility activities of eight antifungal drugs against clinical and environmental isolates of phaeoacremonium species. 6th Conference of Medical Microbiology (FEMS) June 7-11, 2015, Maastricht, the Netherlands


 


31) Sadegh Khodavaisy, Hamid Badali, Sasan Rezaie, Farzad Aala. Antifungal susceptibility of aspergillus flavus recovered from clinical and environmental specimens in Iran. 6th Conference of Medical Microbiology (FEMS) June 7-11, 2015, Maastricht, the Netherlands


 


30) Feng Peiying, Mohammad J. Najafzadeh, Hamid Badali, Sun Jiufeng, Xi Liyan, G. Sybren de Hoog (2015). Identification of common clinical black fungi using RCA technique. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia


29) Mohammad T. Hedayati, Saham Ansari, Kamiar Zomorodian, Keyvan Pakshir, Hamid Badali, Seyedmojtaba Seyedmousavi, Abdollah Rafiei, Mostafa Ravandeh. Antifungal susceptibility testing of clinical dermatophyte isolates from Iran. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia


28) Mohammad H. Afsarian, Hamid Badali, Teun Boekhout, Tahereh Shokohi, Farzad Katiraee. Multilocus sequence typing of Candida albicans isolates from Burn Intensive Care Unit (BICU) in Iran.  Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia


 


27) Sadegh Khodavaisy, Parvaneh Afshar, Mohammad Taghi Hedayati, Hamid Badali. First autochthonous co-infection of anthrax and tinea barbae in Iran.  Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia


26) Sadegh Khodavaisy, Hamid Badali, Peyman Solimani, Samira Salari. Use of PCR-RFLP and PCR-HWP1 for identification of Candida species isolated from cystic fibrosis patients. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia


25) Hamid Badali, Mojtaba Didehdar. First fatal cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran, based on ITSrDNA. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia


24) Hamid Badali, Melika Laal Kargar, G. Sybren de Hoog. Lack of Exophiala dermatitidis in sputum samples of Cystic fibrosis patients in Iran. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia


23)Somayeh Sharifynia, Hamid Badali, Atefe Hadian, Shadi Shahrokhi, Sadegh Khodavaisy, Fatemeh Noorbakhsh, Ghazale Ghandchi, Sassan Rezaie. Molecular identification and antifungal susceptibility of Candida dubliniensis and Candida africana isolated from clinical specimens.  Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia


22) Hamid Badali, Akram Sadeh, Hamed Fakhim, G. Sybren de Hoog, High frequency of Exophiala dermatitidis and E. xenobiotica in railway stations in Iran (2015).  Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia


21) Badali H, Mohseni S, Meis J.F, Klaassen C.H.W (2013). Veronaea botryosa: molecular identification with amplified fragment length polymorphism and in vitro antifungal susceptibility (2014).  Poster presenter at the 16th Trend in Medical Mycology, 11-14 October, Copenhagen, Denmark


20) Badali H, Mohseni S, Khodavaisy S, de Hoog GS (2013). Use of rolling circle amplification to rapidly  identify species of Cladophialophora potentially causing human infection. Poster presenter at the 16th Trend in Medical Mycology, 11-14 October, Copenhagen, Denmark


19) Badali H (2013). Rhinocladiella mackenziei infection: an emerging disease in Middle East. As a speaker at the workshop Black Yeasts and Chromoblastomycosis, 30 November – 1 December, Guangzhou, China.


18) Badali H, Klaassen C.H, Meis J.F, de Hoog G. S (2012). In vitro antifungal susceptibility of eight drugs against Exophiala dermatitidis, a systemic opportunist. Oral presenter at the 18th congress of international society for human and animal mycology 2012, June 10-15, Berlin-Germany


17 S. Hashemi, H. Badali, Bromand, Maryam Sotodeh Anvari, Imaan Haghani (2012). Co- infection endocarditis due to Candida albicans and Candida tropicalis in a drug abusers patient. Poster presenter at the 18th congress of international society for human and animal mycology 2012, June 10-15, Berlin-Germany  


16) H. Badali, S. Fooladi, J. Chander, S. Mohseni, J. Meis, S.G. de Hoog (2012). Multiple subcutaneous cysts due to Exophiala spinifera in an immunocompetent patient. Poster presenter at the 18th congress of international society for human and animal mycology 2012, June 10-15, Berlin-Germany


15) Badali H, Prenafeta-Boldu F.X, Guarro J, Klaassen C.H, Meis J.F, de Hoog G. S (2011). Cladophialophora psammophila, a novel species of Chaetothyriales with a potential use in the bioremediation of volatile aromatic hydrocarbons. Poster presenter at the 5th Trends in Medical Mycology, Valencia, Spain, October 2-5, 2011


14) Badali H, de Hoog GS, Curfs-Breuker I, Klaassen CH, Meis JF. Use of AFLP analysis for identification of 29 neurotropic Cladophialophora isolates with in vitro activities of eight antifungal drugs. As a poster presenter at the 4th Trends in Medical Mycology, Athens, Greece, October 18-21, 2009


13) Badali H, Najafzadeh MJ, de Hoog GS, Curfs-Breuker I, Meis JF. Microdilution in vitro susceptibility of agents of chromoblastomycosis, Fonsecaea pedrosoi and Fonsecaea monophora, for 8 antifungal agents. As a poster presenter at the 4th Trends in Medical Mycology, Athens, Greece, October 18-21, 2009


12) Badali H, Najafzadeh MJ, Vanesbroeck M, Van den Enden E, Meis JF de Hoog GS. The clinically important black yeast, Exophiala jeanselmei and itsin vitro susceptibility to antifungal agents. As a poster presenter at the 4th Trends in Medical Mycology, Athens, Greece, October 18-21, 2009


11) Badali H, de Hoog GS, Curfs-Breuker I, Meis JF. Antifungal activity of isavuconazole and comparators against chromoblastomycotic Cladophialophora spp. As a poster presenter at the 4th Trends in Medical Mycology, Athens, Greece, October 18-21, 2009


10) Badali H, De Hoog GS, Breuker-Curfs I, Andersen B, Meis JF. In Vitro Activities of Eight Antifungal Drugs against 70 Clinical and Environmental Isolates of Alternaria species. As a speaker at the 17th congress of international society for human and animal mycology 2009, May 25-29 Tokyo-Japan.


9) Badali H, De Hoog GS, Breuker-Curfs I, Heep M, Meis JF In vitro activities of conventional and new antifungal drugs against Rhinocladiella mackenziei an agent of cerebral phaeohyphomycosis. As a speaker at the 17th congress of international society for human and animal mycology 2009, May 25-29 Tokyo-Japan.


8) Najafzadeh MJ, Gueidan C, Badali H, Van Den Ende AHG, De Hoog GS. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea. 17th congress of international society for human and animal mycology 2009, May 25-29 Tokyo-Japan.


7) Badali H, Gueidan C, Gerrits van den ende AHG, De Hoog GS. Cladophialophora with an infectious potential occurring in soft drinks. International congress of mycology, IUMS 2008, August 5- 9 Istanbul-Turkey.


6) Badali H, De Hoog GS, Gerrits van den ende AHG, Najafzadeh MJ, Biodiversity of the genus Cladophialophora, agent of human infection, 3rd trend Medical Mycology congress 2007, October 27- 31 Torino-Italy.


5) Najafzadeh MJ, Badali H, Gerrits van den ende AHG, De Hoog GS. Multilocus Sequence Typing (MLST) of the pathogenic genus Fonsecaea. 3rd trend Medical Mycology congress 2007, October 27- 31 Torino-Italy.


4)Badali H, Vicente V, Attili- Angelis D, Kwiatkowski IB, Gerrits van den ende AHG, De Hoog GS, A new, opportunistic species of Cladophialophora. 12th Netherlands Society for Medical Mycology 2007, December.


3) Badali H, Nourian AA, Mohseni S, Haniloo A, Khodaverdi M, Hamzehei H, Airborne fungi isolated from Zanjan–Iran. 12th International Congress on Infection Disease, 2006, June Portugal-Lisbon


2) Hedayati MT, Badali H. Mycoflora of stored wheat in warehouses of Mazandaran Province, Iran. 13t VAM congress 2001, August 27-30, Kuala Lumpur-Malaysia.


1) Hedayati MT, Badali H, Vasheghani F, Aghili R, Mohammad pour RA. Immunoblotting analysis of sera from patients with acute and chronic candidal and noncandidal vaginitis for IgE and IgG antibodies to Candida albicans. 13th European congress of clinical microbiology and infectious diseases, 2003 May 10 -13, Glasgow-UK.


 


Scholarships, Awards and Honors:


1- Scholarship for PhD period in field of Medical Mycology of Ministry of Health and Medical Education of Islamic Republic of Iran from 2006 to 2010.


2- ISHAM young investigators travel award worth 1500 $ for an outstanding presentation at the 17th Congress of The International Society for Human and Animal Mycology, Tokyo, Japan, May 2009


3- ECMM young investigators travel award worth 1000 Euro for an outstanding presentation at the 4th Trends in Medical Mycology, Athens, Greece, October 18-21, 2009


4- FEMS young investigators travel award worth 400 Euro for an outstanding presentation at the 6th Conference of Medical Microbiology (FEMS) June 7-11, 2015, Maastricht, the Netherlands


 


Teaching Experiences


1) Teaching of Medical mycology course for health and medical students in Zanjan university of Medical Science, School of medicine, from 2003 to 2006.


2) Teaching of Medical mycology course for MSc students of Medical Parasitology in Zanjan university of Medical Science, School of medicine, from 2005 to 2006.


3) Teaching of all Medical mycology courses such as fungal genetic, fungal biotechnology and fungal physiology for MSc and PhD students in field of Mycology at Mazandaran university of Medical Science, School of medicine, from 2010 to present.


 


Professional memberships:



  1. Member of the International Society of Human and Animal Mycology (ISHAM).

  2. Member of the Young International Society of Human and Animal Mycology (ISHAM).

  3. Member of the European Society of Clinical Microbiology and Infection Disease (ESCMID).

  4. The Young ISHAM’ representative for Iran, Turkey and Middle East [email protected]

  5. Secretary in Iranian Society of Medical Mycology


[email protected]


 


 Specialization and Interest



  • Epidemiology and clinical courses of severe fungal infections

  •  Antifungal susceptibility testing and to investigate mechanism of actions


Severe fungal infections (Aspergillosis and Candidiasis) have emerged worldwide as an important cause of infections among patients undergoing cancer chemotherapy, haematopoetic stem-cell transplantation, or solid organ transplantation. Therefore to determine; distribution, prevalence, epidemiology and strain diversity, describing novel species, to collect azole resistance species, to identify patient population at risk, to determine the clinical pattern of disease, to characterize in vitro susceptibility, to check in vitro susceptibility and drug-drug combinations and to check experimental antifungal drugs in vitro and in vivo in animal models is highly necessary in the hospital, predicting clinical course and applying adequate and cost-effective therapy.


 


REFEREES:



  1. Professor G. Sybren de Hoog: CBS-KNAW Fungal Biodiversity Centre, Utrecht, Netherlands and  Institute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, Netherlands, Email address: [email protected]

  2. Jacques F. Meis: Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, Netherlands, Email address:[email protected]


 

No items yet!

    No items yet!

    No items yet!

Your experience on this site will be improved by allowing cookies.